FDA Strengthens Warning on Fluoroquinolone Antibiotics
Warning Against Flouroquinolone Antibiotics. The warning label on fluoroquinolone antibiotics, which includes the brand names Levaquin, Cipro, and Avelox, has been revised. The U.S. Food and Drug Administration (FDA) points out that the risks outweigh the benefits in patients with acute sinusitis, acute bronchitis, and uncomplicated … [Read more...] about FDA Strengthens Warning on Fluoroquinolone Antibiotics
Strengthen Gadolinium MRI Dyes Warnings
New Warnings on Gadolinium Regarding Its Association With NSF. Gadolinium-based contrast dyes will now bear new warnings on their labels regarding their association with nephrogenic systemic fibrosis (NSF), according to the Food & Drug Administration (FDA). Gadolinium-based contrast dyes are intravenous drugs approved by the FDA … [Read more...] about Strengthen Gadolinium MRI Dyes Warnings
Erythropoiesis-Stimulating Agents Safety Information
FDA Public Health Advisory About Erythropoiesis-Stimulating Agents. The U.S. Food and Drug Administration (FDA) today issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia. The drugs affected by … [Read more...] about Erythropoiesis-Stimulating Agents Safety Information
